Search

Your search keyword '"Winston, E."' showing total 412 results

Search Constraints

Start Over You searched for: Author "Winston, E." Remove constraint Author: "Winston, E." Database Unpaywall Remove constraint Database: Unpaywall
412 results on '"Winston, E."'

Search Results

3. Vaccine value profile for Neisseria gonorrhoeae

5. Interplay of gut microbiota and host epithelial mitochondrial dysfunction is necessary for the development of spontaneous intestinal inflammation in mice

9. A High-Quality Genome-Scale Model for Rhodococcus opacus Metabolism

10. The Role of Mock Reviewing Sessions in the National Research Mentoring Network Strategic Empowerment Tailored for Health Equity Investigators: A Randomized Controlled Study

12. Characteristics of Mpox Vaccine Recipients Among a Sample of Men Who Have Sex With Men With Presumed Exposure to Mpox

14. Healthy Vaccinee Bias and MenB-FHbp Vaccine Effectiveness Against Gonorrhea

16. Reports of Guillain-Barré Syndrome After COVID-19 Vaccination in the United States

18. Inner mitochondrial membrane protein Prohibitin 1 mediates Nix-induced, Parkin-independent mitophagy

23. Safety Monitoring of COVID-19 mRNA Vaccine Second Booster Doses Among Adults Aged ≥50 Years — United States, March 29, 2022–July 10, 2022

25. Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status — United States, January 12, 2022–March 28, 2022

26. Safety of COVID-19 Vaccination in United States Children Ages 5 to 11 Years

27. Effectiveness of a serogroup B outer membrane vesicle meningococcal vaccine against gonorrhoea: a retrospective observational study

28. Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe

30. Acute and persistent effects of commonly used antibiotics on the gut microbiome and resistome in healthy adults

31. Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12–17 Years — United States, December 9, 2021–February 20, 2022

34. Randomized Controlled Study to Test the Effectiveness of Developmental Network Coaching in the Career Advancement of Diverse Early-Stage Investigators (ESIs): Implementation Challenges and Lessons Learned

35. Safety Monitoring of mRNA Vaccines Administered During the Initial 6 Months of the U.S. COVID-19 Vaccination Program: Reports to Vaccine Adverse Events Reporting System (VAERS) and v-safe

38. COVID-19 Vaccine Safety in Adolescents Aged 12–17 Years — United States, December 14, 2020–July 16, 2021

42. Low SARS-CoV-2 Transmission in Elementary Schools — Salt Lake County, Utah, December 3, 2020–January 31, 2021

43. Strengthening and Sustaining Inter-Institutional Research Collaborations and Partnerships

Catalog

Books, media, physical & digital resources